Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
Yiyun Cao, Joonseok Oh, Mengzhao Xue, et al.
Science (2022) Vol. 378, Iss. 6618
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 298
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 156
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Kelly Fogelson, Pieter C. Dorrestein, Amir Zarrinpar, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1069-1085
Open Access | Times Cited: 76
Intestinal bacteria and colorectal cancer: etiology and treatment
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 57
The microbial landscape of colorectal cancer
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 55
Conditioning of the immune system by the microbiome
Daniel B. Graham, Ramnik J. Xavier
Trends in Immunology (2023) Vol. 44, Iss. 7, pp. 499-511
Open Access | Times Cited: 50
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
Jiaao Sun, Feng Chen, Guangzhen Wu
The ISME Journal (2023) Vol. 17, Iss. 10, pp. 1535-1551
Open Access | Times Cited: 46
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 44
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 40
Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis
Elizabeth Schneider, Kenneth J. O’Riordan, Gerard Clarke, et al.
Nature Metabolism (2024) Vol. 6, Iss. 8, pp. 1454-1478
Closed Access | Times Cited: 36
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course
Melanie Schirmer, Martin Stražar, Julián Ávila-Pacheco, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 209-226.e7
Closed Access | Times Cited: 34
Sophisticated natural products as antibiotics
Kim Lewis, Richard Lee, Heike Brötz‐Oesterhelt, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 39-49
Closed Access | Times Cited: 30
Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases
Guoao Ding, Xuezhi Yang, Ying Li, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 21
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery
Maoyi Li, Nanhui Liu, Jiafei Zhu, et al.
Biomaterials (2024) Vol. 309, pp. 122584-122584
Closed Access | Times Cited: 17
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Iliyan D. Iliev, Ashwin N. Ananthakrishnan, Chun‐Jun Guo
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 3
A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules
Moamen M. Elmassry, Kohei Sugihara, Pranatchareeya Chankhamjon, et al.
Cell Host & Microbe (2025) Vol. 33, Iss. 2, pp. 218-234.e12
Open Access | Times Cited: 2
The human microbiome and cancer: a diagnostic and therapeutic perspective
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 38
Molecular mechanisms in colitis-associated colorectal cancer
Royce Zhou, Noam Harpaz, Steven H. Itzkowitz, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Microbial metabolites in colorectal tumorigenesis and cancer therapy
Yali Liu, Harry Cheuk-Hay Lau, Jun Yu
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 35
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
Carlo Airola, Andrea Severino, Serena Porcari, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 868-868
Open Access | Times Cited: 30
Annotating metabolite mass spectra with domain-inspired chemical formula transformers
Samuel Goldman, Jeremy Wohlwend, Martin Stražar, et al.
Nature Machine Intelligence (2023) Vol. 5, Iss. 9, pp. 965-979
Open Access | Times Cited: 30
Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
Mengjie Zhu, Yijie Song, Yu Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11004-11004
Open Access | Times Cited: 26
Orally Administered Silicon Hydrogen Nanomaterials as Target Therapy to Treat Intestinal Diseases
Kailu Wei, Fei Gong, Jie Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21539-21552
Closed Access | Times Cited: 24
The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development
Rui Dai, Bridget N. Kelly, Amarachi Ike, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 676-676
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top